Consistently, BBIT20 depleted EMT markers, particularly increasing E-cadherin and decreasing MMP-9 in tumour tissues, and markedly reduced the metastatic burden in the liver, a primary site of PDAC metastasis. Here, MMP9 is linked to neoplasm.